Microsoft invests $1B for development of superhuman AI

Microsoft announced an investment of $1 billion in and partnership with OpenAI, a San Francisco-based company co-founded by Elon Musk to develop artificial general intelligence, a type of advanced software with intellectual capabilities equal or superior to humans.

Advertisement

Not only does Microsoft’s investment cement the company’s position as OpenAI’s primary partner for developing and commercializing its AI and AGI technologies, but the partnership will also see the companies collaborating to build supercomputing software for Microsoft’s Azure cloud computing service.

The partnership is built on Microsoft and OpenAI’s shared principles regarding AI ethics and trust, and will advance their goals of using AI to address climate change and other global health and education issues. “Our mission is to ensure that AGI technology benefits all of humanity,” OpenAI CEO Sam Altman said. “We believe it’s crucial that AGI is deployed safely and securely and that its economic benefits are widely distributed.”

More articles on AI:
10 most common AI uses in healthcare
Philips leads $6.8M funding round for AI-driven health tech startup
IBM Watson Health VP Lisa Rometty steps down: 3 notes

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.